Αποτελέσματα Αναζήτησης
2 Αυγ 2023 · This cohort study compares the risk of potential adverse events between mRNA vaccines mRNA-1273 and BNT162b2 for COVID-19 among older US adults.
26 Φεβ 2024 · The study, published in Vaccine, confirmed previously identified rare safety signals for myocarditis and pericarditis after a mRNA vaccine (Pfizer and Moderna) and Guillain-Barré syndrome and cerebral venous sinus thrombosis (CVST) after viral vector vaccines (AstraZeneca).1
Κυριότερες Ειδήσεις
The authors say their multi-country analysis confirmed pre-established links between COVID-19 vaccinations and low risks of myocarditis, pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis.
27 Φεβ 2024 · The Vaccine study confirmed that the Moderna and Pfizer/BioNTech vaccines are linked in rare cases to myocarditis and pericarditis, conditions involving inflammation of the heart muscle...
23 Ιουλ 2024 · We report that the risk of developing most AI-CTDs did not increase following mRNA vaccination, except for systemic lupus erythematosus with a 1.16-fold risk in vaccinated individuals relative...
16 Απρ 2024 · Evidence suggests the two mRNA vaccines do not cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with thrombocytopenia syndrome (TTS), or myocardial infarction (heart attack). Evidence also suggests the Pfizer-BioNTech vaccine does not cause ischemic stroke.
11 Δεκ 2020 · A November survey in 15 countries found 54% of people were worried about possible side effects from a Covid-19 vaccine. One unwanted response to the Pfizer-BioNTech mRNA vaccine came to light during the first day of mass vaccination in the UK after two people with a history of significant allergies reacted to the injection.
